SeaBridge Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,647
Closed -$265K 206
2025
Q4
$265K Sell
10,647
-1,963
-16% -$49.5K 0.04% 176
2025
Q3
$321K Sell
12,610
-280
-2% -$6.91K 0.05% 166
2025
Q2
$312K Sell
12,890
-8,035
-38% -$187K 0.06% 167
2025
Q1
$530K Buy
20,925
+2,492
+14% +$65.2K 0.11% 134
2024
Q4
$489K Sell
18,433
-1,654
-8% -$44.9K 0.1% 144
2024
Q3
$581K Sell
20,087
-89,636
-82% -$2.61M 0.14% 113
2024
Q2
$3.07M Sell
109,723
-3,833
-3% -$106K 0.8% 37
2024
Q1
$3.15M Buy
113,556
+60,236
+113% +$1.67M 0.83% 41
2023
Q4
$1.54M Sell
53,320
-52,625
-50% -$1.59M 0.45% 70
2023
Q3
$3.51M Buy
105,945
+5,186
+5% +$183K 1.16% 24
2023
Q2
$3.7M Sell
100,759
-1,647
-2% -$64.1K 1.21% 19
2023
Q1
$4.18M Sell
102,406
-24,700
-19% -$1.07M 1.46% 15
2022
Q4
$6.51M Sell
127,106
-4,810
-4% -$231K 2.32% 4
2022
Q3
$5.77M Buy
131,916
+2,150
+2% +$104K 2.01% 7
2022
Q2
$6.8M Buy
129,766
+3,325
+3% +$169K 2.18% 6
2022
Q1
$6.55M Sell
126,441
-231
-0.2% -$12K 1.95% 9
2021
Q4
$7.48M Sell
126,672
-8,463
-6% -$419K 2.39% 6
2021
Q3
$5.81M Buy
135,135
+327
+0.2% +$14.5K 1.91% 12
2021
Q2
$5.28M Sell
134,808
-25
-0% -$972 1.7% 13
2021
Q1
$4.88M Sell
134,833
-289
-0.2% -$10.3K 1.61% 17
2020
Q4
$4.97M Sell
135,122
-9,018
-6% -$331K 1.79% 8
2020
Q3
$5.02M Buy
144,140
+82,714
+135% +$2.9M 1.87% 8
2020
Q2
$1.91M Buy
61,426
+200
+0.3% +$6.79K 0.74% 54
2020
Q1
$1.9M Buy
61,226
+241
+0.4% +$8.21K 0.87% 45
2019
Q4
$2.27M Sell
60,985
-8,522
-12% -$304K 0.79% 51
2019
Q3
$2.37M Sell
69,507
-770
-1% -$28K 0.81% 50
2019
Q2
$2.89M Hold
70,277
0.96% 39
2019
Q1
$2.83M Buy
70,277
+390
+0.6% +$15.6K 0.95% 45
2018
Q4
$2.89M Buy
69,887
+2,182
+3% +$90.6K 1.05% 43
2018
Q3
$2.83M Sell
67,705
-337
-0.5% -$13K 0.72% 56
2018
Q2
$2.34M Sell
68,042
-5,765
-8% -$197K 0.58% 63
2018
Q1
$2.48M Sell
73,807
-522
-0.7% -$17.9K 0.56% 61
2017
Q4
$2.55M Sell
74,329
-301
-0.4% -$10.3K 0.56% 66
2017
Q3
$2.53M Buy
74,630
+578
+0.8% +$18.6K 0.59% 65
2017
Q2
$2.36M Buy
74,052
+2,883
+4% +$90.9K 0.57% 67
2017
Q1
$2.31M Buy
71,169
+416
+0.6% +$13.1K 0.55% 67
2016
Q4
$2.18M Sell
70,753
-4,574
-6% -$140K 0.52% 70
2016
Q3
$2.42M Buy
75,327
+1,238
+2% +$41.4K 0.6% 64
2016
Q2
$2.48M Buy
74,089
+54,072
+270% +$1.73M 0.63% 58
2016
Q1
$563K Hold
20,017
0.14% 126
2015
Q4
$613K Sell
20,017
-3,267
-14% -$103K 0.14% 117
2015
Q3
$694K Hold
23,284
0.16% 113
2015
Q2
$741K Hold
23,284
0.15% 104
2015
Q1
$769K Hold
23,284
0.15% 103
2014
Q4
$688K Buy
23,284
+1,370
+6% +$39.3K 0.14% 112
2014
Q3
$615K Sell
21,914
-527
-2% -$14.8K 0.14% 107
2014
Q2
$632K Buy
22,441
+527
+2% +$15K 0.13% 110
2014
Q1
$668K Buy
21,914
+1,624
+8% +$48.4K 0.15% 95
2013
Q4
$590K Hold
20,290
0.13% 106
2013
Q3
$553K Hold
20,290
0.13% 111
2013
Q2
$539K Buy
+20,290
New +$561K 0.14% 109

Other funds holding PFE

SeaBridge Investment Advisors's PFE Position: Q1 2026 in Review

SeaBridge Investment Advisors sold out of Pfizer (PFE) in Q1 2026, closing a stake of 10,647 shares — an estimated $265K sold.

SeaBridge Investment Advisors first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $7.48M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SeaBridge Investment Advisors reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • SeaBridge Investment Advisors sold 10,647 Pfizer shares in Q1 2026, an estimated $265K.
  • SeaBridge Investment Advisors first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
  • SeaBridge Investment Advisors's Pfizer position peaked at $7.48M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SeaBridge Investment Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.